Boston Scientific Corp (BSX) Stock Price, Quote & News

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal sur...

Industry: Medical Devices

Sector: Healthcare

Phone: 508 683 4000

Website: www.bostonscientific.com

Address:

300 Boston Scientific Way, Marlborough, United States

duarteslb Jan. 14 at 9:50 PM

$BSX added here today. only add of the day

0 · Reply

JFDI Jan. 14 at 4:11 PM

$BSX “it’s literally impossible to get ******* to change their diet and lifestyle”

1 · Reply

DragonAlgo Jan. 14 at 8:00 AM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-01-16 | Strike: $95.00 | Type: CALL Option Plan (premium): Entry: $0.65 Stop: $0.47 TP1: $0.85 TP2: $1.10 TP3: $1.56 🔗 https://dragonalgo.com

0 · Reply

SteveWiersteiner414 Jan. 14 at 5:33 AM

$ZM $BSX Tech meets healthcare stability

0 · Reply

SuperGreenToday Jan. 14 at 4:03 AM

$BSX Share Price: $94.09 Contract Selected: Feb 06, 2026 $95 Calls Buy Zone: $2.12 – $2.62 Target Zone: $3.76 – $4.60 Potential Upside: 67% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

trading_momentum_x Jan. 14 at 3:34 AM

$BSX - Boston Scientific is getting Jimmy Whipped right now, although it's arguably the best price for the quality that you can by in USA healthcare

0 · Reply

Steward59 Jan. 13 at 11:27 PM

$BSX despite 2 fucking BUY analyst ratings today this fucking bitch company doesn’t care any rating and keep dropping and going to hell

0 · Reply

ZacksResearch Jan. 13 at 7:03 PM

Margin quality is improving in MedTech — and these 3 names are leading it. 📈 $ANGO, $BSX, and $MDT are seeing earnings quality improve as higher-margin products take share, supporting stronger margins and more durable growth across the MedTech space. See why product mix is becoming a key driver for these stocks 👉 https://www.zacks.com/stock/news/2816795/3-medtech-stocks-benefiting-from-favorable-product-mix-shifts?cid=sm-stocktwits-2-2816795-teaser-28741&ADID=SYND_STOCKTWITS_TWEET_2_2816795_TEASER_28741

0 · Reply

BillionerOfKing Jan. 13 at 6:11 PM

$BSX Current Stock Price: $93.14 Contracts to trade: $95 BSX Jan 16 2026 Call Entry: $0.60 Exit: $0.95 ROI: 58% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

DragonAlgo Jan. 13 at 11:19 AM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-01-16 | Strike: $95.00 | Type: CALL Option Plan (premium): Entry: $1.75 Stop: $1.26 TP1: $2.27 TP2: $2.98 TP3: $4.20 🔗 https://dragonalgo.com

0 · Reply

Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 7:00 AM EST - 2 days ago

Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

Jan 2, 2026, 8:00 AM EST - 12 days ago

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

Dec 28, 2025, 2:40 AM EST - 18 days ago

Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside

Dec 2, 2025, 4:23 PM EST - 6 weeks ago

Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript

Nov 18, 2025, 11:48 AM EST - 2 months ago

Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Nov 6, 2025, 8:10 AM EST - 2 months ago

Artisan Global Opportunities Fund Q3 2025 Portfolio Update

AMZN DKS INSM LHX SPOT TEAM VRTX

Nov 3, 2025, 8:00 AM EST - 2 months ago

Boston Scientific announces upcoming investor conference schedule

Oct 27, 2025, 1:27 PM EDT - 2 months ago

Baron Health Care Fund Q3 2025 Top Contributors And Detractors

ARGX INSM ISRG LLY RDNT

Oct 23, 2025, 11:34 PM EDT - 2 months ago

Boston Scientific Q3: Operational Improvements Warrant An Upgrade To A Buy

Oct 23, 2025, 9:41 AM EDT - 2 months ago

These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings

Oct 22, 2025, 2:53 PM EDT - 3 months ago

Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript

Oct 22, 2025, 7:36 AM EDT - 3 months ago

Boston Scientific lifts annual profit forecast on strong demand for heart devices

Oct 22, 2025, 6:59 AM EDT - 3 months ago

Boston Scientific Raises Outlook on Continued Cardiovascular Growth

Oct 22, 2025, 6:30 AM EDT - 3 months ago

Boston Scientific announces results for third quarter 2025

Oct 21, 2025, 11:07 AM EDT - 3 months ago

It's time to scoop up undervalued stocks in this critical sector of the economy

ISRG SYK BDX BDYN BIO FEGE JGLO

Oct 17, 2025, 7:09 AM EDT - 3 months ago

Boston Scientific buys Nalu Medical for $533 million

Oct 17, 2025, 7:00 AM EDT - 3 months ago

Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

Oct 13, 2025, 2:53 PM EDT - 3 months ago

9 Stocks to Buy Before Their Earnings Reports

ADBE CSCO GM OKTA ZM

Oct 9, 2025, 5:00 AM EDT - 3 months ago

4 Top AI-Powered Healthcare Stocks

OPRX VEEV ZEPP

Sep 30, 2025, 6:12 PM EDT - 3 months ago

Boston Scientific Corporation (BSX) Analyst/Investor Day Transcript

Sep 19, 2025, 7:01 AM EDT - 4 months ago

Top 3 Health Care Stocks That May Explode In September

ATYR RVPH

Sep 2, 2025, 8:00 AM EDT - 4 months ago

Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results

Aug 25, 2025, 2:26 PM EDT - 5 months ago

8 Growth Stocks to Buy That Aren't Technology. What Makes Them Worth It.

COF UBER

Aug 9, 2025, 8:53 AM EDT - 5 months ago

Boston Scientific Corporation Is Expensive But Worth It

Aug 7, 2025, 9:45 PM EDT - 5 months ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX EW EXAS GH ISRG LLY MASI

Aug 6, 2025, 8:07 AM EDT - 5 months ago

Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions

Jul 31, 2025, 9:52 AM EDT - 5 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

CAH DXCM EW ISRG LLY PODD SYK

Jul 23, 2025, 12:10 PM EDT - 6 months ago

Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript

Jul 23, 2025, 10:46 AM EDT - 6 months ago

Cramer's Stop Trading: Boston Scientific

Jul 23, 2025, 7:58 AM EDT - 6 months ago

Boston Scientific lifts annual profit view on steady heart devices demand

Jul 23, 2025, 6:30 AM EDT - 6 months ago

Boston Scientific announces results for second quarter 2025

Jul 22, 2025, 11:00 AM EDT - 6 months ago

How To Trade Boston Scientific Stock Ahead Of Its Upcoming Earnings?

Jul 11, 2025, 5:05 AM EDT - 6 months ago

North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key Companies - Boston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf

Jul 7, 2025, 7:00 AM EDT - 6 months ago

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

Jul 1, 2025, 8:00 AM EDT - 7 months ago

Boston Scientific announces conference call discussing second quarter 2025 results

Jun 16, 2025, 11:00 AM EDT - 7 months ago

What's Happening With Boston Scientific Stock?

Jun 10, 2025, 10:53 AM EDT - 7 months ago

20 stocks bucking bad trends on Wall Street — what might be next for them?

AMT ANET AVGO TRMB BAC C CCL

Jun 6, 2025, 2:42 PM EDT - 7 months ago

3 Growth Stocks That Aren't the Magnificent 7

CYBR

May 30, 2025, 4:45 AM EDT - 8 months ago

Boston Scientific: Old, Reliable; Buy For Their Consistent Growth

May 28, 2025, 3:40 PM EDT - 8 months ago

Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook

May 28, 2025, 12:14 PM EDT - 8 months ago

Boston Scientific Corporation (BSX) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 28, 2025, 8:09 AM EDT - 8 months ago

Boston Scientific to not seek US approval for heart device amid regulatory challenges

May 13, 2025, 3:33 PM EDT - 8 months ago

Boston Scientific Corporation (BSX) Bank of America's 2025 Health Care Conference (Transcript)

Apr 29, 2025, 11:30 AM EDT - 9 months ago

Baron Health Care Fund Q1 2025 Top Contributors And Detractors

ACLX DHR GKOS INSM ISRG LLY RDNT

Apr 24, 2025, 3:41 PM EDT - 9 months ago

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

Apr 24, 2025, 2:13 PM EDT - 9 months ago

Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results

Apr 23, 2025, 11:34 AM EDT - 9 months ago

Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript

Apr 23, 2025, 10:22 AM EDT - 9 months ago

Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition

Apr 23, 2025, 9:56 AM EDT - 9 months ago

Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire

duarteslb Jan. 14 at 9:50 PM

$BSX added here today. only add of the day

0 · Reply

JFDI Jan. 14 at 4:11 PM

$BSX “it’s literally impossible to get ******* to change their diet and lifestyle”

1 · Reply

DragonAlgo Jan. 14 at 8:00 AM

0 · Reply

SteveWiersteiner414 Jan. 14 at 5:33 AM

$ZM $BSX Tech meets healthcare stability

0 · Reply

SuperGreenToday Jan. 14 at 4:03 AM

0 · Reply

trading_momentum_x Jan. 14 at 3:34 AM

$BSX - Boston Scientific is getting Jimmy Whipped right now, although it's arguably the best price for the quality that you can by in USA healthcare

0 · Reply

Steward59 Jan. 13 at 11:27 PM

$BSX despite 2 fucking BUY analyst ratings today this fucking bitch company doesn’t care any rating and keep dropping and going to hell

0 · Reply

ZacksResearch Jan. 13 at 7:03 PM

0 · Reply

BillionerOfKing Jan. 13 at 6:11 PM

0 · Reply

DragonAlgo Jan. 13 at 11:19 AM

0 · Reply

Ravenskys1 Jan. 13 at 1:09 AM

$BSX Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the FARAPOINTTM Pulsed Field Ablation (PFA) Catheter, the first and only focal catheter designed and optimized for PFA. The FARAPOINT PFA Catheter is indicated for adjunctive cavotricuspid isthmus (CTI) ablation when the FARAWAVETM PFA Catheter is used in the treatment of drug refractory, symptomatic persistent atrial fibrillation (AF). 🚀

0 · Reply

Steward59 Jan. 12 at 7:37 PM

$BSX what’s the problem with this bitch???

1 · Reply

Jessypenny Jan. 12 at 7:33 AM

$JPM Week is officially here. I'm Watching these for major updates: $LLY (Eli Lilly) – Focus is on the obesity market and their oral weight-loss pipeline. Expecting big visionary updates. $KRYS (Krystal Biotech) – Just dropped preliminary FY25 results and presenting today. Watch for data on their rare disease genetic medicine pipeline. $BSX (Boston Scientific) – A top pick for 2026. Looking for growth targets in minimally invasive tech and cardiovascular expansion. $RVMD (Revolution Medicines) – High M&A chatter here. Will we see a formal move from Merck.

0 · Reply

j123321 Jan. 11 at 1:37 AM

$RNXT Would targeting both Big Medical Device companies including $BSX or $MDT and Large Pharma company $BMY :)

1 · Reply

wolf12631 Jan. 10 at 2:55 PM

$BSX lower low, lower high

1 · Reply

DragonAlgo Jan. 10 at 1:44 PM

🐉 $BSX CALL — DragonAlgo® VIP Signal Contract: BSX 2026-01-16 C98 Expiry: 2026-01-16 | Strike: 97.50 | Type: CALL Option Plan (premium): Entry: 1.52 Stop: 1.10 TP1: 1.98 TP2: 2.59 TP3: 3.66 TA: Educational only — not financial advice. 🔗 https://dragonalgo.com

0 · Reply

SuperGreenToday Jan. 9 at 5:33 AM

$BSX Share Price: $98.38 Contract Selected: Jan 30, 2026 $100 Calls Buy Zone: $1.40 – $1.73 Target Zone: $2.46 – $3.01 Potential Upside: 66% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

trading_momentum_x Jan. 9 at 4:06 AM

$BSX - Could easily see Boston Scientific pushign the 52-week high 109.50 and surpassing it in the next few months. Hard to keep this quality healthcare gian supressed, any meaningful dip near low-90s has been bought up fast on volume.

0 · Reply

ZacksResearch Jan. 8 at 1:29 PM

$BSX's international expansion is paying off — why it’s set for more growth! 🌍 📈 Strong Q3 sales in emerging markets, up 11.5% operationally YoY 💪 WATCHMAN device sees 35% growth in Q3 2025, driving global market capture ✅ Zacks Rank #2 (Buy) with a history of beating earnings estimates Discover what makes BSX a compelling play here 👉 https://www.zacks.com/stock/news/2814062/is-boston-scientific-stock-a-smart-pick-for-your-portfolio-right-now?cid=sm-stocktwits-2-2814062-body-27924&ADID=SYND_STOCKTWITS_TWEET_2_2814062_BODY_27924

0 · Reply

ZacksResearch Jan. 8 at 12:29 PM

$BSX firing on multiple cylinders — but don’t ignore the risks ⚠️ International growth is coming through, MedSurg is taking market share, and WATCHMAN sales are surging — a strong combo even as macro pressure and competition linger. See the full risk/reward setup here 👉 https://www.zacks.com/stock/news/2814062/is-boston-scientific-stock-a-smart-pick-for-your-portfolio-right-now?cid=sm-stocktwits-2-2814062-teaser-27923&ADID=SYND_STOCKTWITS_TWEET_2_2814062_TEASER_27923

0 · Reply

OMW2Money Jan. 7 at 8:29 PM

$IHI been waiting on this sector for awhile now, is it time for it to finally make a move? $ABT $ISRG $BSX $EW

1 · Reply

jewell69 Jan. 7 at 4:40 PM

since 7/11/25 made Page Total: $714.63 ON $BSX MOST RECENT TRADES 1/7 S 107 11:32 AM EST in 2 trades 98.50 / 60 12/8 b 40 94.1968 this trade took some nerve 12/4 B 97 AT 97.365 was the biggest buy piece recently, so much of the profit here came when I b shares cheaper than that (obviamente, that's what my Peruvian family members always say !)

0 · Reply

Market Cap	139.56B
Revenue (ttm)	16.75B
Net Income (ttm)	1.85B
EPS (ttm)	N/A
PE Ratio	32.45
Forward PE	27.72
Profit Margin	11.07%
Debt to Equity Ratio	0.49

Volume	7,270,300
Avg Vol	8,908,938
Day's Range	N/A - N/A
Shares Out	1.48B
Stochastic %K	13%
Beta	0.67
Analysts	Strong Sell
Price Target	$126.37